These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 31879830)
1. Optimization, in-vitro Release and in-vivo Evaluation of Gliquidone Nanoparticles. Mohamed MS; Abdelhafez WA; Zayed G; Samy AM AAPS PharmSciTech; 2019 Dec; 21(2):35. PubMed ID: 31879830 [TBL] [Abstract][Full Text] [Related]
2. Mohamed MS; Abdelhafez WA; Zayed G; Samy AM Drug Dev Ind Pharm; 2019 Dec; 45(12):1973-1981. PubMed ID: 31692385 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique. Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation. Rao Q; Qiu Z; Huang D; Lu T; Zhang ZJ; Luo D; Pan P; Zhang L; Liu Y; Guan S; Li Q Eur J Pharm Sci; 2019 Feb; 128():222-231. PubMed ID: 30553058 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation. Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653 [TBL] [Abstract][Full Text] [Related]
6. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement. Gera S; Talluri S; Rangaraj N; Sampathi S AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300 [TBL] [Abstract][Full Text] [Related]
7. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations. Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of dissolution and oral bioavailability of gliquidone with hydroxy propyl-beta-cyclodextrin. Sridevi S; Chauhan AS; Chalasani KB; Jain AK; Diwan PV Pharmazie; 2003 Nov; 58(11):807-10. PubMed ID: 14664337 [TBL] [Abstract][Full Text] [Related]
9. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement. Zhang J; Huang Y; Liu D; Gao Y; Qian S Eur J Pharm Sci; 2013 Mar; 48(4-5):740-7. PubMed ID: 23305994 [TBL] [Abstract][Full Text] [Related]
10. Artemisinin-Polyvinylpyrrolidone Composites Prepared by Evaporative Precipitation of Nanosuspension for Dissolution Enhancement. Kakran M; Sahoo NG; Li L; Judeh Z; Panda P J Biomater Sci Polym Ed; 2011; 22(1-3):363-78. PubMed ID: 20566035 [TBL] [Abstract][Full Text] [Related]
11. Characterization and therapeutic efficacy evaluation of glimepiride and L-arginine co-amorphous formulation prepared by supercritical antisolvent process: Influence of molar ratio and preparation methods. Park H; Jin Seo H; Hong SH; Ha ES; Lee S; Kim JS; Baek IH; Kim MS; Hwang SJ Int J Pharm; 2020 May; 581():119232. PubMed ID: 32240805 [TBL] [Abstract][Full Text] [Related]
12. Nanocrystalization of Pioglitazone by Precipitation Method. Varshosaz J; Ahmadipour S; Tabbakhian M; Ahmadipour S Drug Res (Stuttg); 2018 Oct; 68(10):576-583. PubMed ID: 29631296 [TBL] [Abstract][Full Text] [Related]
13. Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition. Rahim H; Sadiq A; Khan S; Amin F; Ullah R; Shahat AA; Mahmood HM Int J Nanomedicine; 2019; 14():6287-6296. PubMed ID: 31496686 [TBL] [Abstract][Full Text] [Related]
14. Design, optimization and in vitro-in vivo evaluation of smart nanocaged carrier delivery of multifunctional PEG-chitosan stabilized silybin nanocrystals. Liu Y; Wang Y; Zhao J Int J Biol Macromol; 2019 Mar; 124():667-680. PubMed ID: 30502425 [TBL] [Abstract][Full Text] [Related]
15. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol. Miao X; Sun C; Jiang T; Zheng L; Wang T; Wang S J Pharm Pharm Sci; 2011; 14(2):196-214. PubMed ID: 21733409 [TBL] [Abstract][Full Text] [Related]
16. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery. Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185 [TBL] [Abstract][Full Text] [Related]
17. Effect of pH and complexation on transdermal permeation of gliquidone. Sridevi S; Diwan PV Pharmazie; 2002 Sep; 57(9):632-4. PubMed ID: 12369452 [TBL] [Abstract][Full Text] [Related]
18. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation. Freag MS; Elnaggar YS; Abdallah OY Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765 [TBL] [Abstract][Full Text] [Related]
19. Preparation and dissolution rate of gliquidone-PVP K30 solid dispersions. Martnez P; Goñi MM; Cantera RG; Martin C; Dios-Viéitez C; Martínez-Ohárriz C Eur J Drug Metab Pharmacokinet; 1998; 23(2):113-7. PubMed ID: 9725467 [TBL] [Abstract][Full Text] [Related]
20. Development of eplerenone nano sono-crystals using factorial design: enhanced solubility and dissolution rate via anti solvent crystallization technique. Yassin GE; Khalifa MKA Drug Dev Ind Pharm; 2022 Dec; 48(12):683-693. PubMed ID: 36533708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]